Orchid Pharma Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 188.86 | 243.74 | 227.28 |
| Operating Expense | 158.75 | 203.15 | 190.98 |
| Net Profit | 18.20 | 27.85 | 23.91 |
| Net Profit Margin | 9.64 | 11.43 | 10.52 |
| Earning Per Share | 3.59 | 5.49 | 4.71 |
| EBIDTA | 30.11 | 40.59 | 36.31 |
| Effective Tax Rate | TBA | TBA | TBA |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 188.86 |
| Operating Expense | 158.75 |
| Net Profit | 18.20 |
| Net Profit Margin | 9.64 |
| Earning Per Share | 3.59 |
| EBIDTA | 30.11 |
| Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 921.93 | 819.37 | 665.90 |
| Operating Expenses Annual | 798.40 | 708.69 | 582.28 |
| Operating Profit Annual | 155.46 | 141.07 | 141.20 |
| Interest Annual | 14.54 | 16.33 | 32.23 |
| Depreciation | 33.93 | 31.75 | 54.74 |
| Net Profit Annual | 106.48 | 94.75 | 55.25 |
| Tax Annual | TBA | -3.23 | TBA |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 921.93 |
| Operating Expenses Annual | 798.40 |
| Operating Profit Annual | 155.46 |
| Interest Annual | 14.54 |
| Depreciation | 33.93 |
| Net Profit Annual | 106.48 |
| Tax Annual | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 0.29 | 18.31 | 0.45 |
| Cash Flow from Operations | 27.48 | 130.73 | 13.39 |
| Cash Flow from Investing | -37.35 | -315.81 | -26.70 |
| Cash Flow from Financing | 25.44 | 167.07 | 31.17 |
| Cash Flow at the End | 15.87 | 0.29 | 18.31 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 0.29 |
| Cash Flow from Operations | 27.48 |
| Cash Flow from Investing | -37.35 |
| Cash Flow from Financing | 25.44 |
| Cash Flow at the End | 15.87 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 16.90 | 17.26 | 15.46 |
| PBIT Margin (%) | 13.17 | 13.21 | 7.23 |
| PBT Margin (%) | 12.29 | 12.42 | 7.01 |
| Net PROFIT Margin (%) | 11.55 | 11.56 | 8.14 |
| Return On Networth / Equity (%) | 3.32 | 3.15 | 0.81 |
| Return On Networth /Employed (%) | 3.61 | 3.33 | 2.34 |
| Return On Assets (%) | 7.39 | 7.75 | 5.37 |
| Total Debt / Equity (X) | 0.12 | 0.24 | 0.43 |
| Asset Turnover Ratio (%) | 0.64 | 0.67 | 0.66 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 16.90 |
| PBIT Margin (%) | 13.17 |
| PBT Margin (%) | 12.29 |
| Net PROFIT Margin (%) | 11.55 |
| Return On Networth / Equity (%) | 3.32 |
| Return On Networth /Employed (%) | 3.61 |
| Return On Assets (%) | 7.39 |
| Total Debt / Equity (X) | 0.12 |
| Asset Turnover Ratio (%) | 0.64 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 629.47 | 630.71 | 573.06 |
| Total Current Assets Annual | 786.39 | 782.29 | 493.79 |
| Non Current Assets Annual | 910.19 | 769.91 | 729.46 |
| Total Shareholders Funds Annual | 1,324.05 | 1,218.32 | 731.96 |
| Total Assets Annual | 1,696.58 | 1,552.20 | 1,223.26 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 629.47 |
| Total Current Assets Annual | 786.39 |
| Non Current Assets Annual | 910.19 |
| Total Shareholders Funds Annual | 1,324.05 |
| Total Assets Annual | 1,696.58 |
EPS (INR)
Expected
2.94
Reported
2.94
Surprise
0.00%
Mar 2025
EPS beaten by 0.00%
Dec 2024
EPS beaten by 0.23%
Sep 2024
EPS beaten by 0.00%
